 ROCKVILLE, Md., Dec. 10, 2020 PRNewswire -- REGENXBIO Inc. Nasdaq: RGNX, a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology Platform, today announced that the first patient has... 